Free Trial
CVE:PTF

Pender Growth Fund (PTF) Stock Price, News & Analysis

Pender Growth Fund logo
C$13.69 -0.31 (-2.21%)
As of 03:59 PM Eastern

About Pender Growth Fund Stock (CVE:PTF)

Key Stats

Today's Range
C$13.68
C$13.69
50-Day Range
C$10.10
C$14.59
52-Week Range
C$9.29
C$14.99
Volume
200 shs
Average Volume
2,910 shs
Market Capitalization
C$99.26 million
P/E Ratio
2.21
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pender Growth Fund and its competitors with MarketBeat's FREE daily newsletter.

PTF Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

PTF Stock Analysis - Frequently Asked Questions

Pender Growth Fund's stock was trading at C$11.19 at the beginning of 2025. Since then, PTF stock has increased by 22.3% and is now trading at C$13.69.

Shares of PTF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pender Growth Fund investors own include Armata Pharmaceuticals (ARMP), BioCardia (BCDA), Bristol Myers Squibb (BMY), Range Cancer Therapeutics ETF (CNCR), Inovio Pharmaceuticals (INO), Insight Select Income Fund (INSI) and Protalix BioTherapeutics (PLX).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
CVE:PTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$6.20
Trailing P/E Ratio
2.21
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$44.92 million
Net Margins
90.98%
Pretax Margin
N/A
Return on Equity
49.26%
Return on Assets
25.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
51.12

Sales & Book Value

Annual Sales
C$49.38 million
Price / Sales
2.01
Cash Flow
C$1.64 per share
Price / Cash Flow
8.35
Book Value
C$15.08 per share
Price / Book
0.91

Miscellaneous

Outstanding Shares
7,250,430
Free Float
N/A
Market Cap
C$99.26 million
Optionable
Not Optionable
Beta
0.56
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (CVE:PTF) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners